Michael John Sumner insider trades

Open-market stock purchases and sales by Michael John Sumner, Chief Medical Officer at Inovio Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 30, 2022.

Recent trades

DateStockTradeValue
May 20, 2026INO Inovio Pharmaceuticals, IncSold (not open market)$3.3K
May 20, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
May 20, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
May 20, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
May 15, 2026INO Inovio Pharmaceuticals, IncSold (not open market)$884
May 15, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Mar 31, 2026INO Inovio Pharmaceuticals, IncSold (not open market)$2.1K
Mar 31, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Feb 26, 2026INO Inovio Pharmaceuticals, IncSold (not open market)$7K
Feb 26, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Feb 26, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—

Companies traded

  • INO Inovio Pharmaceuticals, Inc: other filings, last May 20, 2026

Get free alerts when Michael John Sumner files a new trade →